Natus Medical Incorporated NTUS

Full chart Compare
Set alert

Price alert · NTUS

All alert types
32.96 0.00 (+0.00%)

Apr 24, 2025, 3:47 PM EDT

32.84 Day range 33.07

52-week range unavailable

Market cap
1.14B
Revenue (ttm)
478.30M
Profit margin
2.65%
Shares out
34.58M
Forward P/E
20.99
Volume
132.70K
Open
32.90
Previous close
32.96
Day's range
32.84 – 33.07
Beta
0.23
Analysts
Hold
Earnings date
Aug 4, 2022

2Y +4.61 (+16.26%)

2530Dec 21Jan 22Mar 22May 22Jun 2232.96

Key statistics

Enterprise value
1.05B
PEG ratio
1.04
Price / sales
2.38
Price / book
2.62
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
4.20%
Free cash flow
52.88M
Total cash
84.28M
Total debt
10.24M
Return on equity
3.02%
Short % of float
6.11%
50-day average
32.61
200-day average
27.38

Financials — quick view

All financials
NTUS Revenue — quarterly 119.79M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
NTUS Net income — quarterly 1.90M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
NTUS EPS — quarterly 0.06
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022

Earnings

NTUS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 4, 2022Jun 1, 20220.32———
May 5, 2022Mar 1, 20220.26———
Feb 24, 2022Dec 1, 20210.44———
Nov 4, 2021Sep 1, 20210.30———
Aug 5, 2021Jun 1, 20210.29———
May 6, 2021Mar 1, 20210.16———

Upgrades / downgrades

NTUS analyst upgrades and downgrades
DateFirmActionFromTo
Feb 2, 2017Raymond JamesdownOutperformMarket Perform
Oct 4, 2016Benchmarkinit—Buy
Sep 13, 2016Raymond JamesupMarket PerformOutperform
Apr 5, 2016Roth Capitalmain—Buy
Oct 7, 2014William BlairdownMarket PerformOutperform
May 6, 2013CJS Securitiesinit—Market Perform

About Natus Medical Incorporated

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
natus.com

News

Your note

Sign in to keep a note on NTUS — it syncs with the Stock Master app.

Insider holders

NTUS insider holders
InsiderRelationLatest transactionDateShares held
CHUNG DONG CHUNE CHRISTOPHEROfficerSaleDec 8, 202139,926
DASKAL ILANDirectorStock Award(Grant)Jun 14, 202218,937
DAVIES BENJAMIN DREWChief Financial OfficerStock Award(Grant)Jul 20, 20220
GUERIN ERICDirectorStock Award(Grant)Jun 14, 202210,114
HEINE LISA WIPPERMANDirectorStock Award(Grant)Jun 14, 202226,287
LEVINE JOSHUA HDirectorStock Award(Grant)Jun 14, 202237,387

Institution ownership

NTUS institution ownership
Holder% heldSharesValueReported
Blackrock Inc.18.82%6,506,467214.45MMar 30, 2022
Vanguard Group, Inc. (The)8.85%3,058,873100.82MMar 30, 2022
Victory Capital Management Inc.7.63%2,637,25486.92MMar 30, 2022
Allspring Global Investments Holdings, LLC6.06%2,096,94469.12MMar 30, 2022
Dimensional Fund Advisors LP4.04%1,398,69246.10MMar 30, 2022
State Street Corporation3.89%1,345,37444.34MMar 30, 2022

Fund ownership

NTUS fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF7.08%2,447,19480.66MJun 29, 2022
Victory Portfolios-Sycamore Small Company Opportunity Fund3.94%1,361,00044.86MApr 29, 2022
Janus Henderson Small Cap Value Fund3.23%1,115,72636.77MMar 30, 2022
Vanguard Total Stock Market Index Fund2.82%975,29332.15MMar 30, 2022
Allspring Special Small Cap Value Fund2.81%972,56732.06MMay 30, 2022
iShares Russell 2000 ETF2.26%780,12225.71MJun 29, 2022